GE HealthCare Technologies Inc. (NASDAQ:GEHC) Holdings Raised by Radnor Capital Management LLC

Radnor Capital Management LLC boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,838 shares of the company’s stock after buying an additional 383 shares during the period. Radnor Capital Management LLC’s holdings in GE HealthCare Technologies were worth $829,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Pathway Financial Advisers LLC purchased a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at approximately $25,000. Fred Alger Management LLC acquired a new stake in shares of GE HealthCare Technologies in the second quarter worth $26,000. M&R Capital Management Inc. purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at $33,000. Elkhorn Partners Limited Partnership acquired a new position in GE HealthCare Technologies during the second quarter valued at $31,000. Finally, ORG Partners LLC lifted its stake in GE HealthCare Technologies by 2,475.0% in the 2nd quarter. ORG Partners LLC now owns 412 shares of the company’s stock worth $32,000 after acquiring an additional 396 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

GEHC has been the topic of several research analyst reports. Evercore ISI lifted their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective on the stock. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their target price for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Finally, BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research report on Wednesday, September 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $94.36.

GE HealthCare Technologies Stock Down 1.6 %

GEHC stock opened at $86.78 on Thursday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The company has a 50-day moving average of $88.74 and a two-hundred day moving average of $83.46. The stock has a market capitalization of $39.65 billion, a price-to-earnings ratio of 23.84, a price-to-earnings-growth ratio of 3.12 and a beta of 1.24. GE HealthCare Technologies Inc. has a 52-week low of $66.39 and a 52-week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same quarter last year, the firm posted $0.99 EPS. The company’s revenue was up .9% on a year-over-year basis. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s payout ratio is 3.30%.

Insider Activity

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.